Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
July 2004
Features
Meeting Highlights
Improving Patient Safety and Quality of Care: The P&T Society’s Response to the Challenges of Medication Errors
The author summarizes the P&T Society’s Task Force Report in support of the initiatives undertaken by the Institute of Medicine to reduce medical errors. Opportunities for improvement, “practices of excellence,” and the Society’s perspective are outlined.
Joseph Eichenholz
Meeting Highlights
Fourth Annual Conference of the Pharmacy & Therapeutics Society: Charting the Future
Presentations focused on improving the quality of health care and reducing the occurrence of medical errors. Also included were such topics as the role of the P&T Society, the Institute of Medicine’s agenda for health care quality and the P&T Society’s response, the findings of the Society’s Working Group, the impact of P&T committee decision strategies, the challenges of the economic environment, the Medicare Modernization Act of 2003, and formulary management.
Marvin M. Goldenberg, PhD, RPh, MS
Meeting Highlights
Highlights of the 56th Annual Meeting of the American Academy of Neurology
Recent advances in the treatment of musician’s dystonia, epilepsy, restless legs syndrome, Tourette syndrome, multiple sclerosis, Alzheimer’s disease, and migraine are presented.
Lawrence M. Prescott, PhD
Cover Story
The Use of COX-1–Sparing Agents in the Federal Health System
Dr. Silver reviews the potential benefits of COX-1–sparing drugs. When compared with traditional NSAIDs, the judicious use of the COX-1–sparing agents can have improved effects on the GI tract and provide efficacious pain relief.
David S. Silver, MD
Departments
Letters to the Editor
Editorial
The Pulse of the Nation
David Nash, MD, MBA, presents the results of a survey detailing the public’s concern about medical errors and the quality of health care.
David Nash, MD, MBA
Medication Error
Pain, Paralysis, and Other Dangers of Intrathecal Drugs
Matthew Grissinger, RPh, FASCP, explains the adverse consequences of unintended intrathecal therapy and the precautions to take in order to avoid near-fatal errors.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Promise and Peril in Alzheimer’s Disease Research
Stephen Barlas discusses the need for research on Alzheimer’s disease in today’s climate of restricted funding.
Stephen Barlas
Drug News
New Drugs/Drug News
P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Optimizing Adherence to Highly Active Antiretroviral Therapy: A Focus on Fosamprenavir
The authors review fosamprenavir (Lexiva™) for the treatment of HIV infection.
Nathaniel Eraikhuemen, PharmD, Natalie Perry, PharmD, Evans Branch III, PharmD, Daryl Norwood, PharmD, and Marlon Honeywell, PharmD
